Down syndrome mouse models are looking up

Trends in Molecular Medicine

Volumn 12, Issue 6, 2006, Pages 237-240

  Reeves, Roger H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MATURATION; CHROMOSOME 21; CLINICAL FEATURE; CONGENITAL HEART DISEASE; CONGENITAL HEART MALFORMATION; DOWN SYNDROME; GENE EXPRESSION REGULATION; HETEROZYGOTE; HUMAN; MOLECULAR EVOLUTION; MOSAICISM; NONHUMAN; PATHOGENESIS; PHENOTYPE; SHORT SURVEY; TRISOMY 21;

ANIMALS; CHROMOSOMES, HUMAN, PAIR 21; CRANIOFACIAL ABNORMALITIES; DISEASE MODELS, ANIMAL; DOWN SYNDROME; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART DEFECTS, CONGENITAL; HIPPOCAMPUS; HUMANS; MANDIBLE; MICE; MICE, TRANSGENIC; MOSAICISM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE;

EID: 33745107478     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2006.04.005     Document Type: Short Survey

References (18)

1. Epstein C.J. Down syndrome (trisomy 21). In: Scriver C.R., et al. (Ed). The Metabolic and Molecular Bases of Inherited Disease Vol. 1 (2001), McGraw-Hill 1223-1256
2. Olson L.E., et al. A chromosome 21 critical region does not cause specific down syndrome phenotypes. Science 306 (2004) 687-690
3. Deutsch S., et al. Gene expression variation and expression quantitative trait mapping of human chromosome 21 genes. Hum. Mol. Genet. 14 (2005) 3741-3749
4. Goodbourn S., et al. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81 (2000) 2341-2364
5. O'Doherty A., et al. An aneuploid mouse strain carrying human chromosome 21 with down syndrome phenotypes. Science 309 (2005) 2033-2037
6. Kahlem P., et al. Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome. Genome Res. 14 (2004) 1258-1267
7. Lyle R., et al. Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome. Genome Res. 14 (2004) 1268-1274
8. Pennington B.F., et al. The neuropsychology of Down syndrome: evidence for hippocampal dysfunction. Child Dev. 74 (2003) 75-93
9. Kleschevnikov A.M., et al. Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. J. Neurosci. 24 (2004) 8153-8160
10. Siarey R.J., et al. Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome. Neuropharmacology 38 (1999) 1917-1920
11. Baxter L.L., et al. Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse. Hum. Mol. Genet. 9 (2000) 195-202
12. Richtsmeier J., et al. Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice. Dev. Dyn. 217 (2000) 137-145
13. Ferencz C., et al. Congenital cardiovascular malformations associated with chromosome abnormalities: an epidemiologic study. J. Pediatr. 114 (1989) 79-86
14. Shinohara T., et al. Mice containing a human chromosome 21 model behavioral impairment and cardiac anomalies of Down's syndrome. Hum. Mol. Genet. 10 (2001) 1163-1175
15. Gearhart J., et al. Mouse chimeras composed of trisomy 16 and normal (2N) cells: preliminary studies. Brain Res. Bull. 16 (1986) 815-824
16. Antonarakis S.E., et al. Chromosome 21 and down syndrome: from genomics to pathophysiology. Nat. Rev. Genet. 5 (2004) 725-738
17. Roper R.J., et al. Defective cerebellar response to mitogenic Hedgehog signaling in Down syndrome mice. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 1452-1456
18. Yang Q., et al. Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet 359 (2002) 1019-1025